by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Results Ayahuasca ceremony attendants (N = 57) in the Netherlands and Colombia were assessed before, the day after, and 4 weeks following the ritual. Relative to baseline, ratings of depression and stress significantly decreased after the ayahuasca ceremony and these...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
To sum up, the poor practices relative to modern standards in combination with the context of a compensatory incentive in the retrospective data material raise serious questions about the representativeness of the data examined in the two papers by Larsen. These...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
In summary, this review has provided evidence that the beneficial synergistic effects of MDMA with psychotherapy are attributed, at least in part, to the complex neuropharmacological profile of this entactogen creating a neural setting primed to facilitate new...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
PY dose dependently increased scores of all 5D-ASC core dimensions. Only one subject reacted with transient anxiety to HD PY. Compared with PL, MD and HD PY led to a 50% reduction of performance in the FAIR test. “General inactivation”, “emotional...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
One subject experienced transient hypertension without relation to anxiety or somatic symptoms, but no other significant adverse effects were observed. Marked decreases in OCD symptoms of variable degrees were observed in all subjects during 1 or more of the testing...
